{"entity":{"type":"insider","cik":"0001883804","url":"/insider/0001883804","json_url":"/insider/0001883804.json","name":"Chee Conley","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":2,"first":"2024-09-12","last":"2024-11-20","span_basis":"filed_date"},"name_variants":[{"name":"Chee Conley","source":"filing","n_filings":2,"first_seen":"2024-09-12","last_seen":"2024-11-20"}],"transactions":[{"id":2210268,"accession":"0000950170-24-129380","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-129380","line_url":"/filing/0000950170-24-129380#line-1","is_derivative":false,"issuer_cik":"0001556263","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001556263","owner_cik":"0001883804","owner_name":"Chee Conley","owner_url":"/insider/0001883804","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":134797.0,"shares_display":"134,797","price_per_share":0.1998,"price_display":"0.20","price_state":"stated","total_value":26932.4406,"total_display":"26,932.44","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-20","scope":"insider"},{"id":3216971,"accession":"0000950170-24-105994","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-105994","line_url":"/filing/0000950170-24-105994#line-2","is_derivative":false,"issuer_cik":"0001556263","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001556263","owner_cik":"0001883804","owner_name":"Chee Conley","owner_url":"/insider/0001883804","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.7084,"price_display":"1.71","price_state":"stated","total_value":85420.0,"total_display":"85,420.00","shares_owned_after":122504.0,"shares_owned_after_display":"122,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-11","filed_date":"2024-09-12","scope":"insider"},{"id":3216964,"accession":"0000950170-24-105994","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-105994","line_url":"/filing/0000950170-24-105994#line-1","is_derivative":false,"issuer_cik":"0001556263","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001556263","owner_cik":"0001883804","owner_name":"Chee Conley","owner_url":"/insider/0001883804","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.5052,"price_display":"1.51","price_state":"stated","total_value":75260.0,"total_display":"75,260.00","shares_owned_after":72504.0,"shares_owned_after_display":"72,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001556263","name":"Syros Pharmaceuticals, Inc.","url":"/issuer/0001556263","role":"Director, Officer (President & CEO)","n_filings":2,"first_seen":"2024-09-12","last_seen":"2024-11-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001883804","retrieved_at":"2026-08-21T03:51:03+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}